Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
Michelle M. O’Shaughnessy
ResearcherPublications, citations & collaboration network
Michelle M. O’Shaughnessy is a researcher indexed in ScholarIQ from OpenAlex & ORCID. ScholarIQ records 130 works, 4,434 citations, an h-index of 29 and an i10-index of 58.
130
Works
4,434
Citations
29
h-index
58
i10-index
How has Michelle M. O’Shaughnessy's publication output changed over time?
ScholarIQpublication output · 2013–2023
Output grew100% over the shown period — from 1 works in 2013 to 2 in 2023.
1
1
1
2
1
2
1
2
20132015201620172018201920202023
What are the most-cited papers on Michelle M. O’Shaughnessy?
ScholarIQmost cited works
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Timothy H.J. Goodship, H. Terence Cook, Fádi Fakhouri, Fernando C. Fervenza, Véronique Frémeaux‐Bacchi, David Kavanagh, Carla Nester, Marina Noris, Matthew C. Pickering, Santiago Rodrı́guez de Córdoba, Lubka T. Roumenina, Sanjeev Sethi, Richard J. Smith, Charlie E. Alpers, Gerald B. Appel, Gianluigi Ardissino, Gema Ariceta, Mustafa Arıcı, Arvind Bagga, Ingeborg M. Bajema, Miguel Blasco, Linda Burke, Thomas Cairns, M.C. Carratalá, Vivette D. D’Agati, Mohamed R. Daha, An S. De Vriese, Marie‐Agnès Dragon‐Durey, Agnes B. Fogo, Miriam Galbusera, Daniel P. Gale, Hermann Haller, Sally Johnson, Mihály Józsi, Diana Karpman, Lynne D. Lanning, Moglie Le Quintrec, Christoph Licht, Chantal Loirat, Francisco Monfort, B. Paul Morgan, Laure-Hélène Noël, Michelle M. O’Shaughnessy, Marion Rabant, Éric Rondeau, Piero Ruggenenti, Neil Sheerin, Jenna L.H. Smith, Fabrizio Spoleti, Joshua M. Thurman, Nicole C. A. J. van de Kar, Marina Vivarelli, Peter F. Zipfel
Kidney International. 2016703 CitationsOPEN ACCESS
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Brad H. Rovin, Brad H Rovin, Jonathan Barratt, Hiddo J.L. Heerspink, Charles E. Alpers, Stewart Bieler, Dong-Wan Chae, Ulysses Diva, Jürgen Floege, Loreto Gesualdo, Jula K. Inrig, Donald E. Kohan, Radko Komers, Laura Ann Kooienga, Richard Lafayette, Bart Maes, Robert Małecki, Alex Mercer, Irene L. Noronha, Se Won Oh, Chen Au Peh, Manuel Praga, Priscila Preciado, Jai Radhakrishnan, Michelle N. Rheault, William E. Rote, Sydney C W Tang, Vladimir Tesar, Howard Trachtman, Hernán Trimarchi, James A Tumlin, Muh Geot Wong, Vlado Perkovic, Isabella Abbasciano, Catarina Abrantes, Simone Accarino, Sharon G. Adler, Annika Adoberg, Rouzbeh Afsari, Syeda B. Ahmad, Jafar Ahmed, Wooin Ahn, Bamidele Ajayi, Dariusz Aksamit, Saif Al‐Chalabi, É. Alamartine, Bassam Alchi, Mohammad Ali, Roberta Aliotta, Salem Almaani, Catarina Almeida, Edgar Almeida, Francisco de la Prada Álvarez, Patrícia Marques‐Alves, Francesca Annese, Gerald Appel, Alberto Ortiz Arduan, Maria Arena, Marta Calvo Arevalo, Dariush Arfaania, Carlos Arias, Emma Calatayud Aristoy, Eglė Ašakienė, Sarah Ashley, Ali Assefi, Alba Atenza, Asta Auerbach, Hanna Augustyniak-Bartosik, M Avella, Jonathan Ayling-Smith, Isabelle Ayoub, Christine Ayvazyan, Rocco Baccaro, Asha Bailey, Bruce Baker, Saravanan Balamuthusamy, José Ballarín, Rui Barata, Jerko Barbić, Dunja Barisic, Jonathan Barratt, José C. Barreto, Clara Barrios, Mirco Belingheri, Anna Benesova, Ana Ávila Bernabéu, Wanja Bernhardt, Shamik Bhadra, Luigi Biancone, Anne Blanchard, Elena Boaglio, Davide Bolignano, Andrew S. Bomback, Gustavo Andres Useche Bonilla, M Bordoli, Bhadran Bose, Neil Boudville, Donald Brandon, Donald Brandon, Karen Brown
The Lancet. 2023282 CitationsOPEN ACCESS
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Jürgen Floege, Sean Barbour, Daniel Cattran, Jonathan J. Hogan, Patrick H. Nachman, Sydney Tang, Jack F.M. Wetzels, Michael Cheung, David C. Wheeler, Wolfgang C. Winkelmayer, Brad H. Rovin, Sharon G. Adler, Charles E. Alpers, Isabelle Ayoub, Arvind Bagga, Jonathan Barratt, Dawn J. Caster, Daniel T.M. Chan, Anthony Chang, Jason Choo, H. Terence Cook, Rosanna Coppo, Fernando C. Fervenza, Agnes B. Fogo, J. G. Fox, Keisha L. Gibson, Richard J. Glassock, David C.H. Harris, Elisabeth M Hodson, Elion Hoxha, Kunitoshi Iseki, J. Charles Jennette, Vivekanand Jha, David W. Johnson, Shinya Kaname, Ritsuko Katafuchi, A. Richard Kitching, Richard Lafayette, Philip Kam‐Tao Li, Adrian Liew, Jicheng Lv, Ana Malvar, Shoichi Maruyama, Juan M. Mejía‐Vilet, Marcus J. Moeller, Chi Chiu Mok, Carla Nester, Eisei Noiri, Michelle M. O’Shaughnessy, Seza Özen, Samir M. Parikh, Hyeong Cheon Park, Chen Au Peh, William F. Pendergraft, Matthew C. Pickering, Évangéline Pillebout, Jai Radhakrishnan, Manish Rathi, Dario Roccatello, Pierre Ronco, William E. Smoyer, Vladimı́r Tesař, Joshua M. Thurman, Hernán Trimarchi, Marina Vivarelli, Giles Walters, Angela Yee‐Moon Wang, Scott E. Wenderfer
Kidney International. 2019264 CitationsOPEN ACCESS
C3 Glomerulopathy
Nicholas Medjeral‐Thomas, Michelle M. O’Shaughnessy, John O’Regan, Carol Traynor, Michael Flanagan, Limy Wong, Chia Wei Teoh, Atif Awan, Mary Waldron, Tom Cairns, Patrick O’Kelly, Anthony Dorman, Matthew C. Pickering, Peter J. Conlon, H. Terence Cook
Clinical Journal of the American Society of Nephrology. 2013255 Citations
Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey
Michelle M. O’Shaughnessy, Susan L. Hogan, Bawana D. Thompson, Rosanna Coppo, Agnes B. Fogo, J. Charles Jennette
Nephrology Dialysis Transplantation. 2017237 CitationsOPEN ACCESS
Related on ScholarIQ
Ollscoil na Gaillimhe – University of Galway
Institution
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference
Paper
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
Paper
Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Paper
C3 Glomerulopathy
Paper
Glomerular disease frequencies by race, sex and region: results from the International Kidney Biopsy Survey
Paper